Sunday, 29 May 2022 18:32

: A new generation of ulcerative colitis drugs is in development. Will they be blockbusters for Lilly and Pfizer?

Rate this item
(0 votes)
Pfizer’s promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030. Lilly’s got a drug in development, too.

Read more from our friends at MarketWatch

Read 166 times